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SOX2The hypothalamic-pituitary-adrenal (HPA) axis is an important regulator of energy balance, immune function
and the body's response to stress. Signaling networks governing the initial speciﬁcation of corticotropes, a
major component of this axis, are not fully understood. Loss of function studies indicate that Notch signaling
may be necessary to repress premature differentiation of corticotropes and to promote proliferation of
pituitary progenitors. To elucidate whether Notch signaling must be suppressed in order for corticotrope
differentiation to proceed and whether Notch signaling is sufﬁcient to promote corticotrope proliferation, we
examined the effects of persistent Notch expression in Pomc lineage cells. We show that constitutive
activation of the Notch cascade inhibits the differentiation of both corticotropes andmelanotropes and results
in the suppression of transcription factors required for Pomc expression. Furthermore, persistent Notch
signaling traps cells in the intermediate lobe of the pituitary in a progenitor state, but has no effect on pituitary
proliferation. Undifferentiated cells are eliminated in the ﬁrst two postnatal weeks in thesemice, resulting in a
modest increase in CRH expression in the paraventricular nucleus, hypoplastic adrenal glands and decreased
stress-induced corticosterone levels. Taken together, these ﬁndings show that Notch signaling is sufﬁcient to
prevent corticotrope and melanotrope differentiation, resulting in dysregulation of the HPA axis.rbana-Champaign, 524 Burrill
. Fax: +1 217 333 1133.
man).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The hypothalamic-pituitary-adrenal (HPA) axis is critical to
mediating the body's response to stress. It also functions to regulate
many important homeostatic processes, including immune response
and energy balance. Stressors, either immune or environmental,
activate the release of corticotropin releasing hormone (CRH) from
the paraventricular nucleus (PVN) of the hypothalamus to the
anterior pituitary through the hypothalamo-hypophyseal portal
system. CRH release stimulates the anterior pituitary to synthesize
and release adrenocorticotropic hormone (ACTH), which acts on the
adrenal glands to trigger the release of cortisol (corticosterone in
mice) (Garren, 1968; Vale et al., 1981). Increased cortisol release
results in a number of different physiological effects, including an
increase in glucose production and mobilization and an anti-
inﬂammatory response (Munck et al., 1984). In addition to increased
glucose release, cortisol also exerts negative feedback on both the
hypothalamus and pituitary, inhibiting further release of CRH andACTH (Swanson and Simmons, 1989). Disruption in proper develop-
ment or function at any level of the HPA axis can result in multiple
disorders, including Cushing's syndrome and adrenal insufﬁciency,
which are characterized by increased and decreased levels of cortisol,
respectively (Drouin et al., 2007).
The pituitary, a crucial component of the HPA axis, develops from
an invagination of the oral ectoderm at embryonic day (e) 8.5 in mice.
By e11.5, the developing pituitary pinches off from the underlying oral
ectoderm, forming the structure known as Rathke's pouch (RP). RP
contains all the progenitor cells that are necessary for formation of the
anterior lobe (AL) and intermediate lobe (IL) of the pituitary (Burrows
et al., 1999; Rizzoti and Lovell-Badge, 2005). The AL contains ﬁve
hormone producing cell types, which include thyrotropes, lacto-
tropes, gonadotropes, corticotropes, somatotropes, and lactotropes.
The IL houses a sixth hormone cell type, the melanotropes. Current
models propose that pituitary hormone producing cells are speciﬁed
such that each cell type differentiates during a discrete time during
embryonic development (Pope et al., 2006). Furthermore, it is widely
accepted that cells exiting the cell cycle at the same time migrate
to the same location in the pituitary (Dasen and Rosenfeld, 2001;
Wagner and Thomas, 2007). This synchronized cell speciﬁcation
and migration is thought to be coordinated by opposing gradients of
bonemorphogenetic proteins (BMPs) in the underlying oral ectoderm
and ﬁbroblast growth factors (FGFs) in the ventral diencephalon
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Fig. 1. Persistent expression of NICD results in increases in mRNA levels of Notch targets.
(A) Construct andmating scheme for activated NICD expression in Pomc-expressing cells.
(B) Activated NICD results in modest increases in canonical target mRNA levels in Tg
(gray bars) pituitaries as compared to control (black bars) at e16.5. n=3–5. *:pb0.05.
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indicates that each AL hormone cell type exits the cell cycle at the
same time, with the majority of cells doing so between e11.5 and
e13.5. Furthermore, there is no apparent correlation between the
timing of cell speciﬁcation and cell placement within the gland (Davis
et al., 2011). Based on these observations, it remains unclear how
undifferentiated progenitor cells within the same region of the AL,
exposed to the same chemical gradients, are speciﬁed to become
different cell types.
Although all AL hormone cell types exit the cell cycle at the same
time, corticotropes are the ﬁrst to express hormone beginning at e12.5
(Japón et al., 1994). Melanotropes, found in the IL, exit the cell cycle
after AL hormone producing cells and express hormone beginning at
e16.5 (Davis et al., 2011). Terminal differentiation of corticotropes and
melanotropes is characterized by the expression of pro-opiomelano-
cortin (POMC), a precursor of both ACTH, which is released by
corticotropes, and melanocyte stimulating hormone (αMSH), which
is produced by melanotropes.
Several studies have identiﬁed multiple transcription factors that
activate or inhibit expression of POMC in the pituitary. These include
TPIT (TBX19) (Lamolet et al., 2001; Liu et al., 2001), NEUROD1 (Lamolet
et al., 2004; Poulin et al., 1997), Nur77 (Philips et al., 1997a,b) and BMPs
(Nudi et al., 2005). While these factors are known to regulate Pomc
transcription and thus the terminal differentiation of corticotropes and
melanotropes, it remains unclear which signals are involved in the
speciﬁcation of these cells.
We hypothesize that the Notch signaling pathway, an essential
player in progenitor maintenance and cell fate determination in many
tissues, may play a critical role in the speciﬁcation of corticotropes and
melanotropes. The Notch ligands Delta-like1 and Jagged1, the Notch2
and Notch3 receptors, as well as downstream Notch effectors of the
Hes and Hey families of genes, are present during development in
proliferating progenitors in RP. As cells differentiate and migrate
towards the developing AL, the expression of these molecules is
suppressed (Raetzman et al., 2004; Zhu et al., 2006). Additionally, the
Notch1 and Notch2 receptors, as well as Hes and Hey transcription
factors, are present in pituitary stem cells (Chen et al., 2005, 2006).
Studies have shown that loss of function manipulations of the
Notch signaling pathway result in defects in corticotrope and
melanotrope differentiation. In mice lacking Hes1, a canonical Notch
target, Tpit mRNA expression was found to be increased (Zhu et al.,
2006), suggesting that Notch may be necessary to prevent early
expression of this transcription factor. When both Prop1, a pituitary-
speciﬁc Notch target, and Hes1 are lost, robust premature differen-
tiation of corticotropes is observed (Himes and Raetzman, 2009). A
similar, but more modest, acceleration of Pomc expression is seen in a
pituitary-speciﬁc knockout of Rbpj, the primary mediator of Notch
signaling (Zhu et al., 2006). Taken together, these results suggest
Notch signaling is necessary to prevent differentiation of corticotropes
and may act as a negative regulator of early corticotrope speciﬁcation.
We hypothesize that Notch signaling is sufﬁcient to prevent the
differentiation of corticotropes and melanotropes and that Notch
expression needs to be extinguished for cell differentiation to
proceed.
In order to address this hypothesis, we examined the effects of
persistent expression of activated Notch1 in POMC-expressing cells.
We ﬁnd that Notch signaling is sufﬁcient to prevent differentiation of
these cells, coincident with the suppression of the transcription
factors Tpit and Neurod1. Additionally, we show that these undiffer-
entiated cells maintain progenitor qualities but are eliminated during
the ﬁrst two postnatal weeks. The loss of POMC expression in the
pituitary results in severely hypoplastic adrenal glands and decreased
stress-induced corticosterone levels. Our results indicate that Notch
signaling is both necessary and sufﬁcient to repress corticotrope
differentiation and that alterations in Notch signaling could result in
dysfunction of the HPA axis.Results
NICD expression in melanotropes and corticotropes activates Notch
target genes
To determine the effect of aberrant Notch activity during corticotrope
and melanotrope development, we generated a mouse model with
persistent expressionof the activatedNotch1 intracellular domain (NICD)
in POMC-expressing cells. This mouse was generated from themating of
a RosaNotch ﬂoxed mouse (Murtaugh et al., 2003) to a mouse expressing
Cre recombinase under the control of the Pomc promoter(Balthasar et al.,
2004). POMC is expressed in corticotropes in the AL and inmelanotropes
in the IL. Additionally, POMC is produced by hypothalamic neurons in the
arcuate nucleus. However, these neurons do not innervate pituitary
melanotropes or corticotropes and are formed through different
mechanisms than pituitary cells (Goudreau et al., 1995; Kawano and
Daikoku, 1987; Léránth et al., 1983; McNay et al., 2006; Mezey et al.,
1984;Oertel et al., 1982). In the absence of Cre recombinase, a stop codon
ﬂanked by loxP sites prevents the expression of the single-copy NICD
construct. However, when Cre recombinase is active, the stop codon is
excised allowing for the constitutive expression of NICD in Pomc-
expressing cells (Fig. 1A). Although Notch1 is not normally expressed
during pituitary development, studies have shown that the intracellular
domains of Notch1 and Notch2 can have similar transcriptional activity
(Kraman and McCright, 2005). Furthermore, Notch1 is expressed in the
adult stemcell population (Chenet al., 2005, 2006), indicating itmayplay
a role in cell fate choice or maintaining progenitor cells in the adult
pituitary. Therefore, it is of interest to determine the effects of persistent
Notch1 expression in pituitary cell speciﬁcation during development and
in postnatal progenitor maintenance.
Quantitative RT-PCR for Hes1, Hey1, Hey2 and Heyl was performed
on RosaNotch/+ (control) and RosaNotch/+; Pomc-Cre (Tg) pituitaries at
e16.5 to determine if NICD overexpression results in an increase in
any of the canonical Notch effector genes.
The age e16.5 was chosen to begin analysis since it is the earliest
developmental stage at which POMC expression is present in both
corticotropes and melanotropes. Our results show that Hes1 mRNA
levels are unchanged between the two experimental groups. However,
Hey1, Hey2, and Heyl are all signiﬁcantly increased in Tg pituitaries as
compared to their control counterparts (Fig. 1B). These results indicate
25L.B. Goldberg et al. / Developmental Biology 358 (2011) 23–32that overexpression of Notch in pituitary melanotropes and cortico-
tropes is sufﬁcient to produce a modest change in Notch effector mRNA
levels.
Persistent expression of activated NICD is sufﬁcient to prevent corticotrope
and melanotrope terminal differentiation
Notch signaling is known to regulate the balance between
proliferating progenitors and differentiated cells in many endocrine
organs. Therefore, aberrant Notch signaling could possibly alter the size
or morphology of the developing pituitary. To detect if any such
morphological changes are present in Tg mice, control and Tg pituitary
sections were stained with hematoxylin and eosin. At e16.5, the
morphology and size of the control (Fig. 2A) and Tg (Fig. 2B) pituitariesControl
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Fig. 2. Persistent NICD expression inhibits the differentiation of melanotropes and cortico
hematoxylin and eosin. No differences in morphology were observed between the two group
at e16.5 and are diminished in both lobes of Tg (D) mice. Morphology is similar at p1 in co
control mice (G) and is markedly decreased in Tg pituitaries (H) at p1. RT-PCR at e16.5 reve
stained with DAPI (blue; C,D,G and H) Photos taken at 200×; Scale bars: 50 μm. ****:pb0
AL=anterior lobe. IL=intermediate lobe.appear similar,with all three lobes present in both experimental groups.
The same is true at postnatal day (p) 1 (the day of birth), when
pituitaries of control (Fig. 2E) and Tg (Fig. 2F) mice are histologically
indistinguishable. Since Notch signaling is also implicated in cell
differentiation in many tissues, we used immunohistochemistry to
examinewhether POMC expression is affected by persistently activated
Notch expression at e16.5 and p1. At e16.5, control mice have POMC-
positive cells in the IL and scattered throughout the AL (Fig. 2C). At this
same age, Tgmice have very few POMC-positive cells in either the AL or
IL. (Fig. 2D), indicating theirdifferentiation is preventedby expressionof
NICD. This phenotype persists throughp1,when almost no cells in the IL
or AL of Tg mice are POMC-positive (Fig, 2H), compared to the control
(Fig. 2G). Pomc mRNA levels of control and Tg e16.5 pituitaries were
measured using quantitative RT-PCR to determine if this transcript isTg
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tropes. Coronal sections of control (A) and Tg (B) e16.5 pituitaries were stained with
s. POMC immunoreactive cells (red) are found in the IL and AL of control (C) pituitaries
ntrol (E) and Tg (F) pituitaries. POMC expression (red) is observed in the AL and IL of
als a signiﬁcant decrease in Pomc mRNA in Tg mice as compared to controls (I). Nuclei
.0001. n=5–7 (immunohistochemistry) and n=3–5 (qRT-PCR). PL=posterior lobe.
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observations, Tg mice have signiﬁcantly lower levels of Pomc mRNA as
compared to control littermates (Fig. 2I). Taken together, these data
show that constitutive NICD expression in melanotropes and cortico-
tropes is sufﬁcient to inhibit their differentiation and imply that it is
critical that Notch signaling be suppressed in order for corticotrope and
melanotrope differentiation to proceed.Activated Notch inhibits the transcription of factors necessary for POMC
expression
To better elucidate the mechanism by which Notch inhibits the
differentiation of corticotropes and melanotropes, quantitative RT-PCR
was used to examine the mRNA levels of the transcription factors Tpit,
Neurod1 and Mash1 in control and Tg mice at e16.5. Tpit and Neurod1
have been shown to play a role in the activation of Pomc transcription,
whereas Mash1 appears to be restricted to Pomc containing cells,
although it is not required for Pomc transcription (Lamolet et al., 2001,
2004; Liu et al., 2001; McNay et al., 2006; Poulin et al., 1997; Pulichino
et al., 2003a,b). Tpit, NeuroD1 and Mash1 all show signiﬁcantly lower
mRNA levels in Tgmice as compared to their control counterparts, with
Tpit showing the strongest suppression (Fig. 3). Therefore, Notch
signaling componentsmay directly or indirectly affect the expression of
factors important for terminal differentiation of corticotropes and
melanotropes.Undifferentiated IL cells remain SOX2-positive progenitors
Given that IL cells fail to differentiate when activated NICD is
constitutively expressed, we hypothesized that these cells may retain
markers of pituitary progenitors, such as SOX2 (Fauquier et al., 2008).
In control mice, SOX2-positive cells are seen in the IL in a thin layer
lining the lumen of the pituitary (Figs. 4, A, C, E and G). Conversely, in
Tg mice, nearly every cell in the IL is positive for SOX2, indicating
these cells maintain progenitor cell qualities (Figs. 4, B, D, F and H).
Pax7 is a putative marker of intermediate pituitary progenitors
(Hosoyama et al., 2010) and is expressed throughout the IL in control
mice at p1 (Fig. 4I), however a thin layer of cells lining the pituitary
cleft are mostly Pax7-negative (Figs. 4 K, M, O). Based on localization,
they likely constitute SOX2-positive cells. In Tg mice, Pax7 is also
restricted to the IL (Fig. 4J). However, nearly every cell in the IL,
including those lining the cleft, expresses Pax7 (Figs. 4 L, N, P). Taken
together, these ﬁndings indicate that constitutive NICD expression
results in an increased progenitor population in the IL.Tpit  Neurod1 Mash1
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Fig. 3. Transcription factors regulating Pomc expression are decreased in pituitaries of
NICD expressing mice at p1. Tpit, NeuroD1 and Mash1 mRNA levels are signiﬁcantly
reduced in Tg mice (gray bars) as compared to control (black bars) littermates at e16.5,
as determined by qRT-PCR. * pb0.05. ***: pb0.001. n=3–5.Activated Notch leads to elimination of undifferentiated melanotropes
and corticotropes
Morphology and size of adolescent (p32) control and Tg pituitaries
were examined using hematoxylin and eosin in order to determine if
persistent Notch expression affects pituitary morphology at later ages.
In control pituitaries, a prominent IL is observed surrounding the
posterior lobe (PL) of the pituitary (Fig. 5A). In contrast, the IL of Tgmice
is reduced to a single-cell thick layer surrounding the PL (Fig. 5B). TheAL
and PL look similar in both experimental groups. POMC expression was
analyzed at p32 to determine if the remaining cells in the IL of
adolescent Tg mice express terminal differentiation markers. In control
mice, nearly every cell in the IL expresses POMC(Fig. 5C).However, in Tg
mice, only a handful of the residual IL cells are POMC-positive (Fig. 5D).
In addition, very fewPOMC immunoreactive cells are observed in theAL
of Tg mice (Fig. 5F), as compared to control mice (Fig. 5E). The near
complete loss of POMC-expressing cells was conﬁrmed by quantitative
RT-PCR for Pomc, which shows dramatically lower levels of PomcmRNA
in Tgmice than in control littermates at p32 (Fig. 5G).We also observe a
reduction in Crhr1mRNA in Tgmice, further indicating there is a loss of
bothmelanotropes and corticotropes (data not shown). To determine if
the corticotropes andmelanotropes are able to regenerate in oldermice,
pituitary sections from four-month-old control and Tg mice were
stained for POMC. Similarly, almost no POMC expression was observed
in the AL or IL of Tg mice (data not shown). These results suggest that
expression of activated Notch results in the elimination of undiffer-
entiated melanotropes and corticotropes.
In order to better elucidate the age at which the elimination of
these cells occurs, TUNEL staining was performed at e16.5 and p1. No
differences were observed between control and Tg pituitaries at either
age (data not shown). This indicates that cell death is not initiated until
later postnatal development in Tg mice. In order to determine the
developmental windowwhere IL cells are eliminated, Pax7 RT-PCR was
performed on p5, p7, and p9 control and Tg pituitaries (Fig. 5H). Since
previous results suggest Pax7 is maintained in undifferentiated IL cells
in Tg mice (see Fig. 2J), this approach was an effective method to
determine the age at which IL cells are no longer present. At p5,
pituitaries fromboth control and Tgmice express roughly equal levels of
Pax7, suggestingNICD-containing cells are still present at this age. By p7,
Pax7 levels in Tg mice appear to be suppressed as compared to control
mice. In onep7 Tgmouse, Pax7 levels are visibly reduced as compared to
control, whereas another Tg animal shows near complete loss of Pax7
pituitarymRNA. At p9, all Tg pituitaries examined contain no detectable
levels of Pax7 mRNA, whereas control pituitaries still maintain Pax7
expression. These ﬁndings show that aberrant expression of NICD
results in elimination of NICD-containing cells within the ﬁrst two
postnatal weeks.
Persistently activated NICD expression in POMC-expressing cells results
in HPA axis dysfunction
The effects of NICD expression in corticotropes may be reﬂected in
alterations throughout the HPA axis. Development and function of the
adrenal cortex relies heavily on the release of ACTH from the pituitary
(Estivariz et al., 1982; SimpsonandWaterman, 1988). Therefore, adrenal
glands were compared between control and Tg adolescent mice at p32.
Control mice have visibly larger adrenal glands than Tg counterparts in
both sexes (Fig. 5I). To determine the functional capabilities of the
hypoplastic adrenals in Tg mice, stress-induced corticosterone levels
were measured. Signiﬁcant decreases in levels of corticosterone are
observed in both male and female Tg mice as compared to control
counterparts (Fig. 5J).
Under normal conditions, both corticosterone released from the
adrenal gland and ACTH released from the pituitary can inﬂuence CRH
release at the level of the hypothalamus (Swanson and Simmons,
1989). Given that both corticosterone levels and ACTH-positive cells
Control Tg
SO
X2
D
AP
I
M
er
ge
A
C
E
G
B
D
F
H
PA
X7
D
AP
I
M
er
ge
Control Tg
I J
K L
M N
O P
Fig. 4. IL cells containing NICD express markers of pituitary progenitors. SOX2 (red) is expressed at p1 in the pituitary of control (A) and Tg (B) mice. In control animals, SOX2
immunoreactivity (red) is mostly observed lining the cleft of the pituitary (C, G), with nuclei stained with DAPI (blue; E, G). Although there are also scattered SOX2 immunoreactive
cells in the IL, many cells are not SOX2 immunoreactive (compare E (nuclei stained with DAPI) and G). In contrast, nearly every cell in the IL of Tg mice is immunoreactive for SOX2
(D, compare F (nuclei stainedwith DAPI) and H). Expression of Pax7, amarker of intermediate progenitors was also examined. Pax7 immunoreactive cells (red) are observed in the IL
of control (I) and Tg mice (J) at p1. Many cells lining the pituitary cleft at p1 do not express Pax7 in control mice (K, O with nuclei stained with DAPI (blue; M,O), arrows show Pax7-
negative cell). Nearly every cell in the IL of Tgmice is immunoreactive for Pax7 (L, compare N (nuclei stained with DAPI) and P). Photos taken at 100× (A, B, I and J), 400× (C–H, K–P).
White box (A and I) indicates where higher magniﬁcation photos were taken. Scale bars (A–P): 50 μm. n=4–5.
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hypothalamus would be increased as a result of positive feedback. To
determine differences in CRH expression between Tg and controlmale
mice at p32, immunohistochemical expression of CRH was examined
in the PVN. Tg mice display a slight increase in CRH immunoreactivity
in the medial parvocellular portion of the PVN (PaMP; Supplemental
Fig. 1A,B), a region known to be highly responsive to stress (Renard
et al., 2010). As expected, without colchicine pretreatment to inhibit
axonal transport of peptides, CRH-positive cell bodies in control
animals are hardly detectable, with some immunopositive processes
present. In contrast, Tg animals display immunoreactive CRH-positive
cell bodies as well as neuronal processes, indicating an increased level
of CRH in this region. These data are consistent with CRH localization
in Pomc knockout mice (Smart et al., 2007; Yaswen et al., 1999) and,
taken together with the decreased levels of corticosterone, show that
Notch-induced loss of POMC expression in the pituitary leads to
subsequent dysfunction of the HPA axis.
Activated NICD in melanotropes and corticotropes is not sufﬁcient to
promote their proliferation
Because Notch is known to promote proliferation in many cell types
(Collesi et al., 2008; Solecki et al., 2001; Zhang et al., 2008), we
hypothesized it may have a similar role in corticotropes and melano-
tropes.We, therefore, examined the expression of proliferationmarkers
in p1 control and Tg pituitaries. Ki67, a marker of all stages of the cell
cycle, is observed throughout the AL, IL and PL in control mice (Fig. 6A).
No difference in expression pattern was observed in Tg mice (Fig. 6B),
indicating overall proliferation in Pomc-expressing cells is unaffected by
the constitutive expression of NICD. Phospho-histone-H3 staining was
also performed in order to determine if mitosis is altered in cells
persistently expressing NICD. Again, no visible changes in expression
were observed between control (Fig. 6C) and Tg (Fig. 6D) pituitaries at
p1. Histological observations were conﬁrmed by quantitative RT-PCRanalysis of control and Tg p1 pituitaries, which showed no difference in
MycmRNA levels between the two experimental groups (Fig. 6E). These
results indicate that activated NICD is insufﬁcient to promote prolifer-
ation in undifferentiated Pomc-expressing cells.
Discussion
Disruption in normal corticotrope development or function can
result in various disorders, including isolated ACTH deﬁciency and
Cushing's syndrome (Drouin et al., 2007). Signals controlling the
commitment and speciﬁcation of corticotropes are not well under-
stood, but the Notch signaling pathway has been implicated in these
processes. We have previously demonstrated that global loss of Hes1
and Prop1, two Notch effector genes, results in premature differen-
tiation of corticotropes, indicating this pathway is necessary to
prevent early differentiation of these cells (Himes and Raetzman,
2009). Given this ﬁnding, we hypothesized that Notch signaling is
also sufﬁcient to inhibit the differentiation of both corticotropes and
closely relatedmelanotropes. Using amousemodel inwhich activated
Notch is persistently expressed in these two cell types, we were able
to conﬁrm this hypothesis.
As in many developing tissues, Notch signaling components are
found in RP progenitors and in the adult progenitor population but are
excluded from differentiated cells (Raetzman et al., 2004; Zhu et al.,
2006). The presumptive pituitary progenitor population also contains
the transcription factor SOX2, which is thought to be important in
maintaining pluripotency and inhibiting cell differentiation (Episkopou,
2005; Masui et al., 2007). SOX2 is expressed in isolated adult murine
pituitary progenitors and is mainly localized to a single-cell layer lining
either side of the pituitary cleft in the adult (Rizzoti, 2010). In cochlear
development, suppression of Notch signaling results in a decrease in the
expression of SOX2 and an increase in differentiated cells (Dabdoub
et al., 2008). It is possible that SOX2 is a direct target of the Notch
signaling cascade because luciferase reporter assays have shown that
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28 L.B. Goldberg et al. / Developmental Biology 358 (2011) 23–32NICDhas the ability to activate transcriptionof the SOX2promoter (Ehm
et al., 2010). It is, therefore, not surprising thatweobserve an increase in
SOX2 immunoreactivity in pituitary cells that contain activated Notch.
This increase in SOX2 may correlate with an increase in multipotentControl Tg
A B
C D
Ki
67
PH
3
Fig. 6. Proliferation is unaffected by persistent NICD expression. Ki67 immunohistochem
immunoreactivity (red) was observed. Similarly, no difference in Phospho-histone-H3 imm
p1. Nuclei are visualized with DAPI staining (blue; A–D). Additionally, qRT-PCR showed no c
200×. Scale bars: 50 μm. n=4–5 (immunohistochemistry) and n=4 (RT-PCR).pituitary progenitor cells, and indicates that Notch signaling acts in a
similar fashion in the pituitary as it does in other developing systems.
We observed that inappropriately speciﬁed cells in the pituitary
expressing NICD do not reenter the cell cycle and are eliminatedR
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istry was performed on p1 control (A) and Tg pituitaries (B) and no difference in
unoreactivity (PH3; green) was observed between control (C) and Tg (D) pituitaries at
hange inMycmRNA levels between control and Tg pituitaries at p1 (E). Photos taken at
29L.B. Goldberg et al. / Developmental Biology 358 (2011) 23–32during the ﬁrst two postnatal weeks. Persistent expression of
activated Notch has been shown to induce apoptosis in multiple cell
types, including intestinal and neural progenitors (Fre et al., 2005;
Yang et al., 2004). Although we cannot rule out a role for activated
Notch in inducing apoptosis, it is likely that these cells are eliminated
because they are undifferentiated. Ames dwarf mice, which lack
functional Prop1, have extensive apoptosis in aberrantly undiffer-
entiated cells in the pituitary at p1 and p8 (Ward et al., 2005). This
data supports the hypothesis that undifferentiated pituitary cells
may be more prone to cell death, particularly during periods of sig-
niﬁcant postnatal proliferation (Carbajo-Pérez and Watanabe, 1990;
Taniguchi et al., 2002a,b).
While Notch signaling in early development is known to inﬂuence
the balance between proliferating progenitors and differentiated cells, it
also directs cell fate determination at later stages of development in
many systems. For example, Notch promotes cerebellar granule neuron
precursor proliferation (Solecki et al., 2001), but also promotes radial glia
differentiation and inhibits granule neuron differentiation at later stages
of development (Patten et al., 2003). A similar dual role of Notch is seen
in the intestine where Notch signaling inhibits stem cell differentiation
during embryogenesis but biases cells toward an enterocyte fate
and away from a secretory fate during adulthood (Stanger et al.,
2005).We found that NICD is not sufﬁcient to convertmelanotropes and
corticotropes to an alternate cell fate but instead traps them in a
progenitor state. This is especially clear in the IL where NICD-containing
cells do not adopt another fate, but rather retain progenitor-like
properties. However, since we are altering Notch signaling only after
cells are already committed to becomemelanotropes and corticotropes,
it is possible that Notch inﬂuences cell fate at a different developmental
stage as it does in other tissues discussed above.
Through both gain and loss of function studies, it is clear that Notch
can inﬂuence terminal differentiation of Pomc containing cells (Dutta
et al., 2008; Himes and Raetzman, 2009; Zhu et al., 2006). Molecules
required for Pomc transcription, and therefore for the terminal
differentiation of corticotropes and melanotropes, have been well
characterized. These factors include TPIT (Liu et al., 2001; Pulichinoet al.,
2003b) and NEUROD1(Lamolet et al., 2004; Poulin et al., 1997). In
contrast, BMPs have been shown to inhibit the expression of Pomc in
vitro (Nudi et al., 2005).While these factors are known to regulate Pomc
transcription and thus the terminal differentiation of corticotropes and
melanotropes, it remains unclear which signals are involved in the
speciﬁcation of these cells. Lineage speciﬁcation is likely controlled in
part by extrinsic signals, such as morphogens expressed in the oral
ectoderm and ventral diencephalon surrounding the developing
pituitary.However, cells located in the sameregion during development
do not necessarily develop into the same cell type (Davis et al., 2011),
suggesting intrinsic properties are also likely involved. We hypothesize
that Notch signaling may be one such intrinsic factor. We show that
persistently expressing NICD in corticotropes and melanotropes results
in suppression of Tpit and Neurod1, indicating their expression may
be under the control of the Notch signaling cascade. It is also possible
that the suppression of these transcription factors is a result of the
progenitor-like nature of the cells, which are ectopically expressing
SOX2, and is not a result of their direct regulation by NICD. Future
studieswill benecessary in order toelucidate if andhowNotch signaling
directly regulates these molecules. Taken together with the fact that
Prop1, a direct transcriptional target of Notch signaling, is required for
PIT1 expression and the subsequent differentiation of lactotropes,
somatotropes, and thyrotropes (Gage et al., 1996a,b; Zhu et al., 2006a),
we propose a model by which the Notch signaling pathway regulates
the choice between precursors of the corticotrope and PIT1 lineages
during early pituitary cell speciﬁcation (Fig. 7).
This study is the ﬁrst to show that Notch signaling is sufﬁcient to
inhibit melanotrope and corticotrope differentiation, resulting in loss
of these cells and subsequent HPA axis dysfunction. This mousemodel
physiologically resembles a Pomc knockout mouse (Yaswen et al.,1999) and highlights the importance of Notch signaling in the
regulation of corticotrope ontogeny during HPA axis development.
Our study indicates that subtle alterations in Notch signaling within
POMC lineage cells during early embryonic development can lead to
disruption of the HPA axis at the level of the hypothalamus, as well as
the adrenal gland. Disruption of the HPA axis during development
has signiﬁcant physiological consequences on the body's response
to stress, and can result in multiple disorders, including Cushing's
syndrome and adrenal insufﬁciency (Drouin et al., 2007). Our ﬁndings
are not only important to the study of normal pituitary development,
but also demonstrate how alterations in signaling within cortico-
tropes can contribute to dysfunction along the entire HPA axis.
Materials and methods
Mice
RosaNotch ﬂoxedmice (Murtaugh et al., 2003) were purchased from
Jackson Laboratories (Bar Harbor, ME). A breeding colony was
established and progeny were bred to Pomc-Cre mice (Balthasar et
al., 2004), also purchased from Jackson Laboratories (Bar Harbor, ME).
The resulting progeny all possess one RosaNotch ﬂoxed allele, with half
also expressing Cre recombinase. To genotype the mice, tail biopsies
were obtained and DNA was extracted using a salt-out method. PCR
for the Pomc and Cre alleles was performed as previously described
(Himes and Raetzman, 2009). PCR for the RosaNotch ﬂoxed allele was
performed in a similar manner with the following exceptions. The
primers used to detect this allele were 5′-AAA GTC GCT CTG AGT TGT
TAT-3′, 5′-TAA GCC TGC CCA GAA GAC T-3′ and 5′-GAA AGA CCG CGA
AGA GTT TG-3′. The samples underwent 35 cycles of denaturing at
95 C for 30 s, annealing at 55 C for 30 s, and elongation at 72 C for 60 s,
followed by 72 C for 5 min. All animals were housed in a facility with a
12-hour light–dark cycle and were maintained in accordance with the
University of Illinois at Urbana-Champaign Institutional Animal Care
and Use Committee.
Immunohistochemistry
Mice were sacriﬁced at e16.5, p1, and p32. Embryos and pituitaries
were ﬁxed in 3.7% formaldehyde diluted in phosphate buffered saline
(PBS). Samples were dehydrated through a series of graded ethanol,
embedded coronally in parafﬁn, sectioned to a thickness of 6 μm and
mounted on charged slides. For frozen section preparation used to
detect CRH in the hypothalamus, p32 control and Tg brains were snap
frozen in 2-methylbutane, cryoprotected overnight at 4 °C in 30%
sucrose diluted in PBS, and sectioned at 14 μm.
Parafﬁn sections were deparafﬁnized, rehydrated and washed in
PBS. Samples were then boiled in citrate solution (10 μM citrate, pH6)
for 10 min and cooled for 10 min (for all antibodies except POMC and
CRH). Following antigen retrieval, samples were blocked in a solution
containing 5% normal donkey serum diluted in immunohistochemical
block which contains 3% bovine serum albumin and 0.5% TritonX-100
diluted in PBS. Frozen sections were ﬁxed in 3.7% formaldehyde in PBS
for 30 min and washed in PBS prior to application of blocking solution.
For all immunohistochemistry, blocking was followed by an overnight
incubation at 4 °Cwith primary antibody diluted in immunohistochem-
ical block. Primary antibodies used were raised against the following
peptides: POMC (1:300, Dako, Carpinteria, CA), Sox2 (1:750, Millipore,
Billerica, MA), Pax7 (1:500, Developmental Studies Hybridoma Bank,
Iowa City, IA), Ki67 (1:100, Dako, Carpinteria, CA), phospho-histone-H3
(1:500 Upstate Cell Signaling Solutions, Lake Placid, NY) and CRH
(1:1000, Millipore, Billerica, MA). Slides were then incubated with
biotin-conjugated rat (Ki67), mouse (Pax7) or rabbit (POMC, Sox2,
phospho-histone-H3) secondary antibody diluted in immunohisto-
chemicalblock for onehalf hourat roomtemperature. Thiswas followed
bya series ofwashes anda thirty-minute incubationwith a streptavidin-
Fig. 7. A proposed model for the role of Notch signaling in pituitary cell speciﬁcation. Notch signaling must be repressed for corticotrope, melanotrope and gonadotrope
differentiation to occur. In addition to repressing differentiation, Notch signaling is also necessary for the activation of PROP1, which is required for the emergence of the PIT1 lineage.
Hes1, another Notch effector molecule, is necessary for the speciﬁcation of melanotropes.
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conjugated antibodies were purchased from Jackson ImmunoResearch
(WestGrove, PA) andwere used at a concentration of 1:200. Slideswere
counterstained with 4′,6-diamidino-2-phenylindole (DAPI, 1:1000,
Sigma, St. Louis, MO) and visualized at 100×, 200×, or 400×
magniﬁcation using a Leica DM2560 microscope. Photographs were
taken using a Retiga 2000R color camera (Q-Imaging, Surrey, Canada)
and acquired using Q-Capture Pro software (Q-Imaging). Images were
processed using Adobe Photoshop CS4 (San José, CA).
Quantitative reverse transcriptase PCR
RNA was isolated from embryonic and postnatal whole pituitaries
using an RNAqueous micro kit (Ambion, Austin, TX) as per manufac-
turer’s protocol. For p32 pituitaries, 0.5 μg of RNA was synthesized into
cDNA using the ProtoScript M-MuLV First Strand cDNA Synthesis Kit
(New England Biolabs, Ipswich, MA). For e16.5 and p1 pituitaries, RNA
was isolated from individual pituitaries of each genotype and the total
RNA from each pituitarywas converted into cDNA. A no enzyme control
was also prepared and used as a negative control. For quantitative RT-
PCR 0.2 μL of cDNA from p32 and p1 pituitaries and 0.5 μL from e16.5
pituitaries was ampliﬁed using gene-speciﬁc primers and SYBR green
mix (Bio-Rad Laboratories, Hercules, CA) on a Bio-Rad MyIQ real-time
PCR machine. Data were analyzed with the change in cycle threshold
(ΔCt) value method. Speciﬁcally, for each sample, the mean Ct of the
gene of interest was calculated as an average of the duplicates of that
sample. This normalized mean was subtracted from the mean Ct for
Gapdh to obtain theΔCt. TheΔΔCtwas then calculated as the difference
between the ΔCt for each Tg and each control mouse. The relative fold
changeof Tgmice as compared to controlmicewas calculated as 2−ΔΔCt.
The error bars represent the standard error of the mean of the relative
fold change. Statistical signiﬁcance was determined using Student's
t test.
Gene speciﬁc primers for Quantitative RT-PCR include: Gapdh
forward, GGT GAG GCC GGT GCT GAG TAT G; Gapdh reverse, GAC CCG
TTTGGC TCC ACC CTT C;Hes1 forward, CTCGCT CAC TTCGGACTC;Hes1
reverse, GTG GGC TAG GGA CTT TAC; Hey1 forward, CAC GCC ACT ATG
CTC AAT;Hey1 reverse, CCT TCA CCT CAC TGC TCTG;Hey2 forward, GAT
TCC GAG AGT GCT TGA C; Hey2 reverse, AGG TGC TGA GAT GAG AGA C;
Heyl forward,GGAACAACAGAGAATGAAC;Heyl reverse, CAGCAGTAG
TGA GTA ACC; Pomc forward, GTT ACG GTG GCT TCA TGA CCT C; Pomc
reverse, CGC GTT CTT GAT GAT GGC GTT C; Tpit forward, GATGCC AAGGAG AGA AAC C; Tpit reverse, AGC TTT TCT ATC AAA TTC ACT GA;
Neurod1 forward, GCCCAGCTTAATGCCATCTTTC; Neurod1 reverse, AGC
CAC AGT GGA TTC GTT TCC C; Mash1 forward, TGG ACT TTG GAA GCA
GGA TGG; Mash1 reverse, TGA CGT CGT TGG CGA GAA ACA; Myc
forward, TGA CCT AAC TCGAGGAGGAGC TGGAAT C;Myc reverse, AAG
TTT GAG GCA GTT AAA ATT ATG GCT GAA GC.
Reverse transcriptase PCR
RNA and cDNA from p5, p7 and p9 pituitaries were prepared in the
same way as described above with the exception that 0.33 μL of cDNA
was ampliﬁed. Ampliﬁcationwas performed using Pax7 speciﬁc primers
on a C1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA).
Ampliﬁcation was visualized using an ethidium bromide stained gel.
Sequences of primers used: Pax7 forward, GCA CAG AGG ACC AAG CTC
AC; Pax7 reverse TGG TGG TGG GGT AGG TAG AG.
Corticosterone assay and adrenal collection
p32 mice were subjected to 1 h of restraint stress in a ventilated
50 mL conical tube beginning at 1500 h. At 1600 h,micewere sacriﬁced
using CO2. Blood was collected by cardiac puncture and allowed to clot
for 30 min in EDTA-coated tubes. Bloodwas spundown and plasmawas
collected and stored at−20 °C until needed. A corticosterone Enzyme
Immunoassay kit (Assay Designs, Ann Arbor, MI) was used to measure
plasma corticosterone levels as permanufacturer’s protocol. All samples
were run in duplicate and statistical signiﬁcance was determined using
Student's t test. Adrenals were dissected from p32 male and female
mice. They were ﬁxed overnight in 3.7% formaldehyde diluted in PBS,
washed in PBS and photographed.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.07.004.
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